- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT02643225
The Role of Umbilical Cord Thickness in Prediction of Fetal Macrosomia in Patients With Gestational Diabetes Mellitus
The Role of Umbilical Cord Thickness, Interventricular Septum Thickness and HbA1C Levels in Prediction of Fetal Macrosomia in Patients With Gestational Diabetes Mellitus
The aim of this work is the prediction of fetal macrosomia by measuring:
- HbA1C.
- Umbilical cord thickness.
- Interventricular septum thickness.
Visão geral do estudo
Status
Condições
Descrição detalhada
This prospective case control study will be carried out at Ain shams university maternity hospital between April 2015 and October 2015 on 80 patients. The patients will be divided into two groups, 40 pregnant women as case group with gestational diabetes mellitus and 40 non diabetic pregnant women as control group after being approved by the local hospital ethics and research committee. A verbal consent will be taken from each patient.
The following investigation will be performed:
Calculation of gestational age will be based on the last reliable menstrual period or ultrasound examination within the first trimester.
The ultrasound examination will be with Voluson E6 equipped with a 3.5 Hz trans-abdominal probe at fetal medicine unit of maternity hospital Ain Shams University.
Ultrasound examination will be performed twice at 27-28 weeks and 36-37 weeks of gestation prospectively.
During ultrasound, fetal biometry (biparietal diameter, abdominal circumference, femur length) and estimated fetal weight will be calculated automatically according to hadlock's formula additionally, the sonographic cross sectional area of umbilical cord, the umbilical arteries and umbilical vein will be measured in a free loop of the umbilical cord using the software of the ultrasound device.
The cross sectional area of Wharton's jelly will be computed by subtracting the cross sectional area of the vessels from that of the umbilical cord and the interventricular septum thickness will be measured.
- HbA1c levels will be measured for diabetes patients.
All the patients will be subjected to :
- Full history taking including last menstrual period, medical history and past obstetric history.
- Detailed general physical history examination and obstetrics examination.
- Ultrasound examination in fetal medicine unit maternity hospital Ain shams university.
- Venous blood samples will be taken from patients with gestational diabetes mellitus in clinical pathology department Ain Shams University, to measure the level of HbA1c using immunoassay technique. The patients will be followed up till delivery. The neonates will be weighed and fetal macrosomia will be diagnosed if fetal weight is 4 kg or more.
Tipo de estudo
Inscrição (Real)
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
- Singleton gestation.
- Gestational age over 27 weeks.
- Intact membranes.
- Normal umbilical morphology (two arteries and one vein).
- Diagnosis of gestational diabetes.
Exclusion Criteria:
- The presence of fetal congenital anomalies.
- Multifetal pregnancy.
- Maternal chronic diseases (hypertension, renal disease, cardiac and pulmonary disease, etc.).
- Patients with a diagnosis such as oligohydramnios , pre-eclampsia and intrauterine growth retardation.
- Patients who used cigarettes or alcohol during pregnancy.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
---|
pregnant women with gestational diabetes
case group
|
non diabetic pregnant women
control group
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
The Number of Participants Who Were Diagnosed With Fetal Macrosomia (Birth Weight)
Prazo: at birth
|
The neonates will be weighed and fetal macrosomia will be diagnosed if fetal weight is 4 kg or more.
|
at birth
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Umbilical Cordcross-sectional Area
Prazo: 36-37 weeks of gestation
|
the sonographic cross sectional area of umbilical cord, the umbilical arteries and umbilical vein will be measured in a free loop of the umbilical cord using the software of the ultrasound device.
|
36-37 weeks of gestation
|
Prediction of Fetal Macrosomia by Measuring HbA1C in Participants
Prazo: 36-37 weeks of gestation
|
Venous blood samples will be taken from participants in clinical pathology department Ain Shams University, to measure the level of HbA1c using immunoassay technique.
|
36-37 weeks of gestation
|
Interventricular Septum Thickness
Prazo: 36-37 weeks of gestation
|
The interventricular septum thickness will be measured by ultrasound examination
|
36-37 weeks of gestation
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Estimativa)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- Diabetes mellitus
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .